{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:44:51Z","timestamp":1770835491771,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovative Program for Doctoral Students of the First Affiliated Hospital of Chongqing Medical University","award":["CYYY-BSYJSCXXM-202328"],"award-info":[{"award-number":["CYYY-BSYJSCXXM-202328"]}]},{"name":"Chongqing Young and Middle-aged High-end Medical Talents Project Fund","award":["2023GDRC013"],"award-info":[{"award-number":["2023GDRC013"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303655"],"award-info":[{"award-number":["82303655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Chongqing Municipal Science and Technology Commission Doctoral Through Train Project","award":["CSTB2022BSXM-JCX0037"],"award-info":[{"award-number":["CSTB2022BSXM-JCX0037"]}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M740452"],"award-info":[{"award-number":["2023M740452"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the First Clinical College of Clinical Medicine First-class Discipline Construction Program","award":["472020320230017"],"award-info":[{"award-number":["472020320230017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93674-2","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:50:53Z","timestamp":1742219453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive analysis of RNA methylation-related genes to identify molecular cluster for predicting prognosis and immune profiles in bladder cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junrui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"93674_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144, 1941\u20131953 (2019).","journal-title":"Int. J. Cancer"},{"key":"93674_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"93674_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes, J. A. et al. European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. Eur. Urol. 79, 82\u2013104 (2021).","journal-title":"Eur. Urol."},{"key":"93674_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/JU.0000000000002242","volume":"207","author":"AP Mitra","year":"2022","unstructured":"Mitra, A. P. et al. Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: Evolution of the university of Southern California experience over 3,347 cases. J. Urol. 207, 302\u2013313 (2022).","journal-title":"J. Urol."},{"key":"93674_CR5","first-page":"15","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala, K. et al. Epidemiology of bladder cancer. Med. Sci. (Basel) 8, 15 (2020).","journal-title":"Med. Sci. (Basel)"},{"key":"93674_CR6","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye, M., Harada, B. T., Behm, M. & He, C. RNA modifications modulate gene expression during development. Science 361, 1346\u20131349 (2018).","journal-title":"Science"},{"key":"93674_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12943-020-01194-6","volume":"19","author":"H Shi","year":"2020","unstructured":"Shi, H., Chai, P., Jia, R. & Fan, X. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the Bridge between transcription and translation. Mol. Cancer 19, 78 (2020).","journal-title":"Mol. Cancer"},{"key":"93674_CR8","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.7150\/ijbs.61439","volume":"17","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. The role of RNA m(5)C modification in cancer metastasis. Int. J. Biol. Sci. 17, 3369\u20133380 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"93674_CR9","doi-asserted-by":"publisher","first-page":"981392","DOI":"10.3389\/fgene.2022.981392","volume":"13","author":"K Li","year":"2022","unstructured":"Li, K. & Wang, W. Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer. Front. Genet. 13, 981392 (2022).","journal-title":"Front. Genet."},{"key":"93674_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He, L. et al. Functions of N6-methyladenosine and its role in cancer. Mol. Cancer 18, 176 (2019).","journal-title":"Mol. Cancer"},{"key":"93674_CR11","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1200\/JCO.2009.25.0977","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee, J. S. et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J. Clin. Oncol. 28, 2660\u20132667 (2010).","journal-title":"J. Clin. Oncol."},{"key":"93674_CR12","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-09-3323","volume":"16","author":"YJ Kim","year":"2010","unstructured":"Kim, Y. J. et al. Gene signatures for the prediction of response to bacillus calmette-guerin immunotherapy in primary pT1 bladder cancers. Clin. Cancer Res. 16, 2131\u20132137 (2010).","journal-title":"Clin. Cancer Res."},{"key":"93674_CR13","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.3390\/ijms19124080","volume":"19","author":"C Tomikawa","year":"2018","unstructured":"Tomikawa, C. 7-Methylguanosine modifications in transfer RNA (tRNA). Int. J. Mol. Sci. 19, 4080 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"93674_CR14","doi-asserted-by":"publisher","first-page":"1030766","DOI":"10.3389\/fphar.2022.1030766","volume":"13","author":"X Ye","year":"2022","unstructured":"Ye, X. et al. m(6)A\/ m(1)A \/m(5)C\/m(7)G-related methylation modification patterns and immune characterization in prostate cancer. Front. Pharmacol. 13, 1030766 (2022).","journal-title":"Front. Pharmacol."},{"key":"93674_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"93674_CR16","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1093\/annonc\/mdx518","volume":"28","author":"A Necchi","year":"2017","unstructured":"Necchi, A. et al. Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: Post-progression outcomes from the phase II IMvigor210 study. Ann. Oncol. 28, 3044\u20133050 (2017).","journal-title":"Ann. Oncol."},{"key":"93674_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13073-020-0720-0","volume":"12","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles. Genome Med. 12, 24 (2020).","journal-title":"Genome Med."},{"key":"93674_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41419-021-04479-w","volume":"13","author":"H Yin","year":"2022","unstructured":"Yin, H. et al. EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation. Cell. Death Dis. 13, 39 (2022).","journal-title":"Cell. Death Dis."},{"key":"93674_CR19","doi-asserted-by":"publisher","first-page":"114839","DOI":"10.1016\/j.biopha.2023.114839","volume":"163","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. The roles and mechanism of m(6)A RNA methylation regulators in cancer immunity. Biomed. Pharmacother. 163, 114839 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"93674_CR20","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1002\/ctm2.402","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clin. Transl. Med. 11, e402 (2021).","journal-title":"Clin. Transl. Med."},{"key":"93674_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","volume":"18","author":"J Han","year":"2019","unstructured":"Han, J. et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner. Mol. Cancer 18, 110 (2019).","journal-title":"Mol. Cancer"},{"key":"93674_CR22","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1002\/ctm2.675","volume":"11","author":"X Ying","year":"2021","unstructured":"Ying, X. et al. METTL1-m(7) G-EGFR\/EFEMP1 axis promotes the bladder cancer development. Clin. Transl. Med. 11, e675 (2021).","journal-title":"Clin. Transl. Med."},{"key":"93674_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41419-023-05661-y","volume":"14","author":"N Wang","year":"2023","unstructured":"Wang, N. et al. m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6\/TK1 mRNAs splicing and stabilization. Cell. Death Dis. 14, 139 (2023).","journal-title":"Cell. Death Dis."},{"key":"93674_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbcan.2018.09.002","volume":"1870","author":"AE Yuzhalin","year":"2018","unstructured":"Yuzhalin, A. E., Lim, S. Y., Kutikhin, A. G. & Gordon-Weeks, A. N. Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis. Biochim. Biophys. Acta Rev. Cancer. 1870, 207\u2013228 (2018).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"93674_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejso.2011.01.004","volume":"37","author":"GL Yang","year":"2011","unstructured":"Yang, G. L. et al. Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer. Eur. J. Surg. Oncol. 37, 265\u2013271 (2011).","journal-title":"Eur. J. Surg. Oncol."},{"key":"93674_CR26","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1007\/s12011-022-03510-1","volume":"201","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Fibronectin 1 as a key gene in the genesis and progression of cadmium-related bladder cancer. Biol. Trace Elem. Res. 201, 4349\u20134359 (2023).","journal-title":"Biol. Trace Elem. Res."},{"key":"93674_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/annonc\/mdu037","volume":"25","author":"WT Kim","year":"2014","unstructured":"Kim, W. T. et al. S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy. Ann. Oncol. 25, 974\u2013979 (2014).","journal-title":"Ann. Oncol."},{"key":"93674_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fonc.2020.00641","volume":"10","author":"G Efthymiou","year":"2020","unstructured":"Efthymiou, G. et al. Shaping up the tumor microenvironment with cellular fibronectin. Front. Oncol. 10, 641 (2020).","journal-title":"Front. Oncol."},{"key":"93674_CR29","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1002\/jcb.26651","volume":"119","author":"X Cai","year":"2018","unstructured":"Cai, X. et al. Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion. J. Cell. Biochem. 119, 4717\u20134728 (2018).","journal-title":"J. Cell. Biochem."},{"key":"93674_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.31083\/j.fbl2907240","volume":"29","author":"J Yan","year":"2024","unstructured":"Yan, J., Wu, L., Zheng, M. & Pan, F. Exploring programmed cell death-related biomarkers and disease therapy strategy in nasopharyngeal carcinoma using transcriptomics. Front. Biosci. (Landmark Ed). 29, 240 (2024).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"93674_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13062-024-00481-2","volume":"19","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1\/PI3K\/AKT pathway. Biol. Direct. 19, 42 (2024).","journal-title":"Biol. Direct"},{"key":"93674_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40364-024-00662-1","volume":"12","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Single-cell RNA sequencing identifies a subtype of FN1+\u2009tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy. Biomark. Res. 12, 114 (2024).","journal-title":"Biomark. Res."},{"key":"93674_CR33","doi-asserted-by":"publisher","first-page":"753563","DOI":"10.3389\/fmolb.2021.753563","volume":"8","author":"S Sheng","year":"2021","unstructured":"Sheng, S. et al. Aberrant methylation and immune microenvironment are associated with overexpressed fibronectin 1: A diagnostic and prognostic target in head and neck squamous cell carcinoma. Front. Mol. Biosci. 8, 753563 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"93674_CR34","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.2147\/IJGM.S364708","volume":"15","author":"WH Zhou","year":"2022","unstructured":"Zhou, W. H. et al. The overexpression of fibronectin 1 promotes Cancer progression and associated with M2 macrophages polarization in head and neck squamous cell carcinoma patients. Int. J. Gen. Med. 15, 5027\u20135042 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"93674_CR35","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1158\/0008-5472.CAN-08-2132","volume":"68","author":"W Liu","year":"2008","unstructured":"Liu, W., Cheng, S., Asa, S. L. & Ezzat, S. The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res. 68, 8104\u20138112 (2008).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93674-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:51:05Z","timestamp":1742219465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93674-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93674-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval number: 20182101), and written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"All listed authors have actively participated in the study and have read and.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"9147"}}